Share Price and Basic Stock Data
Last Updated: December 8, 2025, 3:58 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Balgopal Commercial Ltd operates in the trading and distribution sector, a space that often thrives on volume and market reach. The company’s revenue trajectory has seen significant fluctuations over the past fiscal years. For instance, in FY 2023, it recorded sales of ₹8.19 Cr, which was a slight uptick from ₹8.00 Cr in FY 2022. However, the company’s performance in subsequent quarters indicates a remarkably strong resurgence, with Q2 FY 2024 sales soaring to ₹17.05 Cr, a clear sign of a rebound. This surge suggests that Balgopal may be capitalizing on improved demand dynamics or perhaps optimizing its distribution strategies. Yet, the erratic nature of its quarterly sales, which saw a dip to ₹0.56 Cr in FY 2025, raises questions about sustainability and market consistency. Retail investors should be cautious here; while the recent performance is promising, the volatility could pose challenges.
Profitability and Efficiency Metrics
When examining profitability, Balgopal’s operating profit margins (OPM) have shown a remarkable recovery, particularly in Q2 FY 2024, where it stood at an impressive 13.84%. This is a stark contrast to previous years, where margins often dipped into negative territory, as seen in FY 2020 with an OPM of -88.97%. The net profit in FY 2024 was reported at ₹13.17 Cr, reflecting a substantial improvement compared to the meager ₹0.30 Cr in FY 2022. However, the company has experienced a few quarters of negative net profit in the past, such as a loss of ₹3.78 Cr in Q4 FY 2023. While the upward trend in profitability is heartening, the history of inconsistent margins indicates a need for Balgopal to maintain operational efficiency to ensure that these gains are sustainable.
Balance Sheet Strength and Financial Ratios
Balgopal Commercial Ltd’s balance sheet appears robust, particularly due to the absence of borrowings, which stood at ₹0.00 Cr across several periods. This zero-debt status provides a cushion against financial stress, allowing the company to navigate market challenges without the burden of interest payments. The reserves have also shown a remarkable increase, from ₹1.29 Cr in FY 2018 to ₹37.65 Cr in FY 2025, enhancing the company’s financial flexibility. However, the current ratio, standing at 3.40, suggests that while the company is liquid, it may also indicate an underutilization of assets. The P/BV ratio of 5.48x could be perceived as high, indicating that the stock might be overvalued compared to its book value, which could deter value-focused investors. Overall, while the balance sheet is strong, the valuation metrics warrant careful consideration.
Shareholding Pattern and Investor Confidence
The shareholding structure of Balgopal Commercial Ltd has undergone a significant transformation, especially with the promoters increasing their stake to 45.42% as of June 2025, up from just 6.31% in December 2022. This dramatic rise in promoter holdings could signal a strong belief in the company’s future prospects, potentially boosting investor confidence. The public shareholding, however, has declined from 93.68% in December 2022 to 54.56% in June 2025, suggesting that some retail investors may have exited during periods of volatility. The increase in promoter confidence, coupled with a solid number of shareholders at 1,464, indicates a growing interest in the company. However, the declining public stake raises questions about retail investor sentiment, which could be influenced by the company’s erratic revenue trends and profitability history.
Outlook, Risks, and Final Insight
Looking ahead, Balgopal Commercial Ltd presents a mixed bag for potential investors. On one hand, the recent uptick in sales and profitability indicates that the company may be on the right track toward recovery and growth. The strong promoter backing adds a layer of confidence, suggesting that those closest to the business are optimistic about its future. Conversely, the volatility in revenue and net profit, coupled with a high P/BV ratio, poses significant risks. Investors must weigh the potential for continued growth against the backdrop of past performance inconsistencies. Furthermore, the absence of foreign and domestic institutional investors may indicate a lack of broader market confidence. Retail investors should remain vigilant, keeping an eye on operational performance and market conditions, as these will ultimately dictate the stock’s trajectory.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Balgopal Commercial Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minal Industries Ltd | 59.7 Cr. | 3.11 | 5.59/3.10 | 39.8 | 2.78 | 0.00 % | 5.97 % | 2.83 % | 2.00 |
| Mitshi India Ltd | 12.1 Cr. | 13.7 | 18.6/13.0 | 3.09 | 0.00 % | 0.36 % | 0.37 % | 10.0 | |
| Modella Woollens Ltd | 6.03 Cr. | 66.2 | 74.8/52.5 | 4.95 | 0.00 % | % | % | 10.0 | |
| MRC Agrotech Ltd | 101 Cr. | 49.4 | 54.5/10.2 | 112 | 15.1 | 0.00 % | 5.89 % | 4.46 % | 10.0 |
| MRP Agro Ltd | 107 Cr. | 96.0 | 174/84.4 | 15.1 | 30.6 | 0.00 % | 39.2 % | 30.3 % | 10.0 |
| Industry Average | 10,424.13 Cr | 160.19 | 89.70 | 120.92 | 0.41% | 15.37% | 8.86% | 7.74 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.17 | 3.93 | 2.01 | 1.08 | 1.00 | 6.03 | 8.92 | 1.09 | 0.05 | 0.33 | 0.18 | 0.00 | 0.00 |
| Expenses | 1.12 | 3.81 | 2.00 | 1.17 | 0.97 | 4.62 | 7.69 | 1.39 | 0.22 | 0.24 | 0.45 | 0.36 | 0.30 |
| Operating Profit | 0.05 | 0.12 | 0.01 | -0.09 | 0.03 | 1.41 | 1.23 | -0.30 | -0.17 | 0.09 | -0.27 | -0.36 | -0.30 |
| OPM % | 4.27% | 3.05% | 0.50% | -8.33% | 3.00% | 23.38% | 13.79% | -27.52% | -340.00% | 27.27% | -150.00% | ||
| Other Income | 0.04 | 1.84 | 1.87 | -3.81 | 2.07 | 2.74 | 2.74 | 4.23 | 4.69 | 7.93 | 0.17 | -4.65 | 2.34 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.09 | 1.96 | 1.88 | -3.90 | 2.10 | 4.15 | 3.97 | 3.93 | 4.52 | 8.02 | -0.10 | -5.01 | 2.04 |
| Tax % | -377.78% | 10.71% | 5.85% | -3.08% | 23.33% | 0.72% | 6.80% | 5.09% | 14.16% | 11.35% | 170.00% | -12.57% | 17.65% |
| Net Profit | 0.43 | 1.75 | 1.77 | -3.78 | 1.61 | 4.11 | 3.70 | 3.74 | 3.88 | 7.10 | -0.27 | -4.38 | 1.68 |
| EPS in Rs | 0.26 | 1.06 | 1.07 | -2.29 | 0.98 | 2.49 | 2.24 | 2.27 | 2.35 | 4.30 | -0.16 | -2.30 | 0.88 |
Last Updated: August 19, 2025, 10:45 pm
Below is a detailed analysis of the quarterly data for Balgopal Commercial Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Expenses, as of Jun 2025, the value is 0.30 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.36 Cr. (Mar 2025) to 0.30 Cr., marking a decrease of 0.06 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.30 Cr.. The value appears strong and on an upward trend. It has increased from -0.36 Cr. (Mar 2025) to -0.30 Cr., marking an increase of 0.06 Cr..
- For OPM %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
- For Other Income, as of Jun 2025, the value is 2.34 Cr.. The value appears strong and on an upward trend. It has increased from -4.65 Cr. (Mar 2025) to 2.34 Cr., marking an increase of 6.99 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 2.04 Cr.. The value appears strong and on an upward trend. It has increased from -5.01 Cr. (Mar 2025) to 2.04 Cr., marking an increase of 7.05 Cr..
- For Tax %, as of Jun 2025, the value is 17.65%. The value appears to be increasing, which may not be favorable. It has increased from -12.57% (Mar 2025) to 17.65%, marking an increase of 30.22%.
- For Net Profit, as of Jun 2025, the value is 1.68 Cr.. The value appears strong and on an upward trend. It has increased from -4.38 Cr. (Mar 2025) to 1.68 Cr., marking an increase of 6.06 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.88. The value appears strong and on an upward trend. It has increased from -2.30 (Mar 2025) to 0.88, marking an increase of 3.18.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:49 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.81 | 3.81 | 2.60 | 4.57 | 14.80 | 16.40 | 9.61 | 5.36 | 8.00 | 8.19 | 17.05 | 0.56 | 0.51 |
| Expenses | 0.80 | 4.13 | 3.00 | 5.22 | 15.97 | 19.79 | 18.16 | 6.13 | 8.55 | 8.00 | 14.69 | 1.27 | 1.35 |
| Operating Profit | 0.01 | -0.32 | -0.40 | -0.65 | -1.17 | -3.39 | -8.55 | -0.77 | -0.55 | 0.19 | 2.36 | -0.71 | -0.84 |
| OPM % | 1.23% | -8.40% | -15.38% | -14.22% | -7.91% | -20.67% | -88.97% | -14.37% | -6.88% | 2.32% | 13.84% | -126.79% | -164.71% |
| Other Income | 0.00 | 0.40 | 0.45 | 0.70 | 0.82 | 1.29 | 1.57 | 7.52 | 0.92 | -0.05 | 11.79 | 8.14 | 5.79 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.01 | 0.08 | 0.05 | 0.05 | -0.35 | -2.10 | -6.98 | 6.75 | 0.37 | 0.04 | 14.15 | 7.43 | 4.95 |
| Tax % | 0.00% | 25.00% | 40.00% | 20.00% | -8.57% | 6.19% | -8.17% | 14.52% | 18.92% | -350.00% | 7.00% | 14.67% | |
| Net Profit | 0.00 | 0.06 | 0.03 | 0.05 | -0.32 | -2.24 | -6.42 | 5.77 | 0.30 | 0.17 | 13.17 | 6.34 | 4.13 |
| EPS in Rs | 0.00 | 0.04 | 0.02 | 0.03 | -0.19 | -1.36 | -3.89 | 3.49 | 0.18 | 0.10 | 7.98 | 3.34 | 2.72 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -50.00% | 66.67% | -740.00% | -600.00% | -186.61% | 189.88% | -94.80% | -43.33% | 7647.06% | -51.86% |
| Change in YoY Net Profit Growth (%) | 0.00% | 116.67% | -806.67% | 140.00% | 413.39% | 376.48% | -284.68% | 51.47% | 7690.39% | -7698.92% |
Balgopal Commercial Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -17% |
| 5 Years: | -43% |
| 3 Years: | -59% |
| TTM: | -97% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 59% |
| 5 Years: | 24% |
| 3 Years: | 185% |
| TTM: | -73% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 137% |
| 1 Year: | 165% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 12% |
| 3 Years: | 10% |
| Last Year: | 15% |
Last Updated: September 5, 2025, 2:36 pm
Balance Sheet
Last Updated: October 10, 2025, 3:35 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.24 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 16.51 | 19.01 |
| Reserves | 17.75 | 1.54 | 1.57 | 1.61 | 1.29 | -0.95 | -7.36 | -1.59 | -1.27 | -1.10 | 12.07 | 37.65 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.00 | 4.24 | 0.02 | 0.46 | 0.47 | 0.11 | 0.39 | 1.35 | 3.53 | 2.23 | 6.17 | 7.81 |
| Total Liabilities | 17.99 | 22.29 | 18.10 | 18.58 | 18.27 | 15.67 | 9.54 | 16.52 | 18.77 | 17.64 | 34.75 | 64.47 |
| Fixed Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 7.42 | 2.40 | 5.79 | 7.42 | 3.60 | 4.28 | 4.48 | 11.44 | 16.89 | 7.28 | 21.09 | 40.03 |
| Other Assets | 10.57 | 19.89 | 12.31 | 11.16 | 14.67 | 11.39 | 5.06 | 5.08 | 1.88 | 10.36 | 13.66 | 24.44 |
| Total Assets | 17.99 | 22.29 | 18.10 | 18.58 | 18.27 | 15.67 | 9.54 | 16.52 | 18.77 | 17.64 | 34.75 | 64.47 |
Below is a detailed analysis of the balance sheet data for Balgopal Commercial Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 19.01 Cr.. The value appears strong and on an upward trend. It has increased from 16.51 Cr. (Mar 2024) to 19.01 Cr., marking an increase of 2.50 Cr..
- For Reserves, as of Mar 2025, the value is 37.65 Cr.. The value appears strong and on an upward trend. It has increased from 12.07 Cr. (Mar 2024) to 37.65 Cr., marking an increase of 25.58 Cr..
- For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 7.81 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.17 Cr. (Mar 2024) to 7.81 Cr., marking an increase of 1.64 Cr..
- For Total Liabilities, as of Mar 2025, the value is 64.47 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 34.75 Cr. (Mar 2024) to 64.47 Cr., marking an increase of 29.72 Cr..
- For Fixed Assets, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 40.03 Cr.. The value appears strong and on an upward trend. It has increased from 21.09 Cr. (Mar 2024) to 40.03 Cr., marking an increase of 18.94 Cr..
- For Other Assets, as of Mar 2025, the value is 24.44 Cr.. The value appears strong and on an upward trend. It has increased from 13.66 Cr. (Mar 2024) to 24.44 Cr., marking an increase of 10.78 Cr..
- For Total Assets, as of Mar 2025, the value is 64.47 Cr.. The value appears strong and on an upward trend. It has increased from 34.75 Cr. (Mar 2024) to 64.47 Cr., marking an increase of 29.72 Cr..
Notably, the Reserves (37.65 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.01 | -0.32 | -0.40 | -0.65 | -1.17 | -3.39 | -8.55 | -1.02 | -0.55 | 0.19 | 2.36 | -0.71 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 365.00 | 233.75 | 4.21 | 112.61 | 195.57 | 107.94 | 109.01 | 121.89 | 15.06 | 25.85 | 0.00 | 0.00 |
| Inventory Days | 2,737.50 | 780.21 | 1,056.29 | 411.08 | 114.63 | 61.12 | 0.00 | 47.74 | 68.23 | 280.44 | 14.79 | |
| Days Payable | 0.00 | 407.49 | 0.00 | 32.92 | 11.15 | 0.00 | 46.27 | 97.68 | 88.38 | 0.00 | ||
| Cash Conversion Cycle | 3,102.50 | 606.48 | 1,060.50 | 490.78 | 299.04 | 169.06 | 109.01 | 123.36 | -14.39 | 217.90 | 14.79 | 0.00 |
| Working Capital Days | 4,763.02 | 1,491.61 | 1,715.50 | 852.20 | 349.22 | 251.94 | 158.76 | 264.90 | -53.84 | 365.45 | 160.34 | 6,537.41 |
| ROCE % | 0.06% | 0.44% | 0.28% | 0.28% | -1.11% | -12.59% | -56.50% | 55.51% | -1.97% | -16.64% | 17.50% | 14.81% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 15 | Mar 14 |
|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 3.70 | 0.04 | 0.12 |
| Diluted EPS (Rs.) | 3.52 | 0.04 | 0.12 |
| Cash EPS (Rs.) | 3.31 | 0.03 | 0.15 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 29.77 | 10.99 | 757.55 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 29.77 | 10.99 | 757.55 |
| Revenue From Operations / Share (Rs.) | 0.29 | 2.56 | 33.95 |
| PBDIT / Share (Rs.) | 3.88 | 0.04 | 0.22 |
| PBIT / Share (Rs.) | 3.88 | 0.04 | 0.19 |
| PBT / Share (Rs.) | 3.88 | 0.04 | 0.19 |
| Net Profit / Share (Rs.) | 3.31 | 0.03 | 0.11 |
| NP After MI And SOA / Share (Rs.) | 3.31 | 0.03 | 0.11 |
| PBDIT Margin (%) | 1320.40 | 1.84 | 0.66 |
| PBIT Margin (%) | 1320.40 | 1.84 | 0.56 |
| PBT Margin (%) | 1320.40 | 1.84 | 0.56 |
| Net Profit Margin (%) | 1125.53 | 1.39 | 0.34 |
| NP After MI And SOA Margin (%) | 1125.53 | 1.39 | 0.34 |
| Return on Networth / Equity (%) | 11.12 | 0.32 | 0.01 |
| Return on Capital Employeed (%) | 12.50 | 0.42 | 0.02 |
| Return On Assets (%) | 9.49 | 0.26 | 0.01 |
| Long Term Debt / Equity (X) | 0.02 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.02 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.00 | 0.20 | 0.00 |
| Current Ratio (X) | 3.40 | 4.69 | 3112.46 |
| Quick Ratio (X) | 1.66 | 2.79 | 1349.68 |
| Enterprise Value (Cr.) | 308.25 | 0.00 | 0.00 |
| EV / Net Operating Revenue (X) | 551.24 | 0.00 | 0.00 |
| EV / EBITDA (X) | 41.75 | 0.00 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 554.80 | 0.00 | 0.00 |
| Price / BV (X) | 5.48 | 0.00 | 0.00 |
| Price / Net Operating Revenue (X) | 555.10 | 0.00 | 0.00 |
| EarningsYield | 0.02 | 0.00 | 0.00 |
After reviewing the key financial ratios for Balgopal Commercial Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 15) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.70. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 15) to 3.70, marking an increase of 3.66.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.52. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 15) to 3.52, marking an increase of 3.48.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.31. This value is within the healthy range. It has increased from 0.03 (Mar 15) to 3.31, marking an increase of 3.28.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.77. It has increased from 10.99 (Mar 15) to 29.77, marking an increase of 18.78.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 29.77. It has increased from 10.99 (Mar 15) to 29.77, marking an increase of 18.78.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.29. It has decreased from 2.56 (Mar 15) to 0.29, marking a decrease of 2.27.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 3.88. This value is within the healthy range. It has increased from 0.04 (Mar 15) to 3.88, marking an increase of 3.84.
- For PBIT / Share (Rs.), as of Mar 25, the value is 3.88. This value is within the healthy range. It has increased from 0.04 (Mar 15) to 3.88, marking an increase of 3.84.
- For PBT / Share (Rs.), as of Mar 25, the value is 3.88. This value is within the healthy range. It has increased from 0.04 (Mar 15) to 3.88, marking an increase of 3.84.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.31. This value is within the healthy range. It has increased from 0.03 (Mar 15) to 3.31, marking an increase of 3.28.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.31. This value is within the healthy range. It has increased from 0.03 (Mar 15) to 3.31, marking an increase of 3.28.
- For PBDIT Margin (%), as of Mar 25, the value is 1,320.40. This value is within the healthy range. It has increased from 1.84 (Mar 15) to 1,320.40, marking an increase of 1,318.56.
- For PBIT Margin (%), as of Mar 25, the value is 1,320.40. This value exceeds the healthy maximum of 20. It has increased from 1.84 (Mar 15) to 1,320.40, marking an increase of 1,318.56.
- For PBT Margin (%), as of Mar 25, the value is 1,320.40. This value is within the healthy range. It has increased from 1.84 (Mar 15) to 1,320.40, marking an increase of 1,318.56.
- For Net Profit Margin (%), as of Mar 25, the value is 1,125.53. This value exceeds the healthy maximum of 10. It has increased from 1.39 (Mar 15) to 1,125.53, marking an increase of 1,124.14.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 1,125.53. This value exceeds the healthy maximum of 20. It has increased from 1.39 (Mar 15) to 1,125.53, marking an increase of 1,124.14.
- For Return on Networth / Equity (%), as of Mar 25, the value is 11.12. This value is below the healthy minimum of 15. It has increased from 0.32 (Mar 15) to 11.12, marking an increase of 10.80.
- For Return on Capital Employeed (%), as of Mar 25, the value is 12.50. This value is within the healthy range. It has increased from 0.42 (Mar 15) to 12.50, marking an increase of 12.08.
- For Return On Assets (%), as of Mar 25, the value is 9.49. This value is within the healthy range. It has increased from 0.26 (Mar 15) to 9.49, marking an increase of 9.23.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 15) to 0.02, marking an increase of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has increased from 0.00 (Mar 15) to 0.02, marking an increase of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. It has decreased from 0.20 (Mar 15) to 0.00, marking a decrease of 0.20.
- For Current Ratio (X), as of Mar 25, the value is 3.40. This value exceeds the healthy maximum of 3. It has decreased from 4.69 (Mar 15) to 3.40, marking a decrease of 1.29.
- For Quick Ratio (X), as of Mar 25, the value is 1.66. This value is within the healthy range. It has decreased from 2.79 (Mar 15) to 1.66, marking a decrease of 1.13.
- For Enterprise Value (Cr.), as of Mar 25, the value is 308.25. It has increased from 0.00 (Mar 15) to 308.25, marking an increase of 308.25.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 551.24. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 15) to 551.24, marking an increase of 551.24.
- For EV / EBITDA (X), as of Mar 25, the value is 41.75. This value exceeds the healthy maximum of 15. It has increased from 0.00 (Mar 15) to 41.75, marking an increase of 41.75.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 554.80. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 15) to 554.80, marking an increase of 554.80.
- For Price / BV (X), as of Mar 25, the value is 5.48. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 15) to 5.48, marking an increase of 5.48.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 555.10. This value exceeds the healthy maximum of 3. It has increased from 0.00 (Mar 15) to 555.10, marking an increase of 555.10.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 15) to 0.02, marking an increase of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Balgopal Commercial Ltd:
- Net Profit Margin: 1125.53%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12.5% (Industry Average ROCE: 15.37%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 11.12% (Industry Average ROE: 8.86%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.66
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 89.7)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.02
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1125.53%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Trading & Distributors | Flat No. B-002, Dreamax Vega, Upadhyay Compound, Pump House, Mumbai Maharashtra 400093 | info@bcommercial.org http://www.bcommercial.org |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Vijay Laltaprasad Yadav | Managing Director |
| Mr. Yash Saraogi | Non Executive Director |
| Mrs. Shrena Kalpesh Shah | Ind. Non-Executive Director |
| Ms. Shailesh Becharbhai Patel | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Balgopal Commercial Ltd?
Balgopal Commercial Ltd's intrinsic value (as of 08 December 2025) is 47.19 which is 77.64% lower the current market price of 211.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 401 Cr. market cap, FY2025-2026 high/low of 273/71.0, reserves of ₹37.65 Cr, and liabilities of 64.47 Cr.
What is the Market Cap of Balgopal Commercial Ltd?
The Market Cap of Balgopal Commercial Ltd is 401 Cr..
What is the current Stock Price of Balgopal Commercial Ltd as on 08 December 2025?
The current stock price of Balgopal Commercial Ltd as on 08 December 2025 is 211.
What is the High / Low of Balgopal Commercial Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Balgopal Commercial Ltd stocks is 273/71.0.
What is the Stock P/E of Balgopal Commercial Ltd?
The Stock P/E of Balgopal Commercial Ltd is .
What is the Book Value of Balgopal Commercial Ltd?
The Book Value of Balgopal Commercial Ltd is 30.6.
What is the Dividend Yield of Balgopal Commercial Ltd?
The Dividend Yield of Balgopal Commercial Ltd is 0.00 %.
What is the ROCE of Balgopal Commercial Ltd?
The ROCE of Balgopal Commercial Ltd is 14.8 %.
What is the ROE of Balgopal Commercial Ltd?
The ROE of Balgopal Commercial Ltd is 12.6 %.
What is the Face Value of Balgopal Commercial Ltd?
The Face Value of Balgopal Commercial Ltd is 10.0.